Literature DB >> 20938240

Image quantification for radiation dose calculations--limitations and uncertainties.

J M Pereira1, M G Stabin, F R A Lima, M I C C Guimarães, J W Forrester.   

Abstract

Radiation dose calculations in nuclear medicine depend on quantification of activity via planar and/or tomographic imaging methods. However, both methods have inherent limitations, and the accuracy of activity estimates varies with object size, background levels, and other variables. The goal of this study was to evaluate the limitations of quantitative imaging with planar and single photon emission computed tomography (SPECT) approaches, with a focus on activity quantification for use in calculating absorbed dose estimates for normal organs and tumors. To do this we studied a series of phantoms of varying complexity of geometry, with three radionuclides whose decay schemes varied from simple to complex. Four aqueous concentrations of ⁹⁹mTc, ¹³¹I, and ¹¹¹In (74, 185, 370, and 740 kBq mL⁻¹) were placed in spheres of four different sizes in a water-filled phantom, with three different levels of activity in the surrounding water. Planar and SPECT images of the phantoms were obtained on a modern SPECT/computed tomography (CT) system. These radionuclides and concentration/background studies were repeated using a cardiac phantom and a modified torso phantom with liver and "tumor" regions containing the radionuclide concentrations and with the same varying background levels. Planar quantification was performed using the geometric mean approach, with attenuation correction (AC), and with and without scatter corrections (SC and NSC). SPECT images were reconstructed using attenuation maps (AM) for AC; scatter windows were used to perform SC during image reconstruction. For spherical sources with corrected data, good accuracy was observed (generally within ±10% of known values) for the largest sphere (11.5 mL) and for both planar and SPECT methods with ⁹⁹mTc and ¹³¹I, but were poorest and deviated from known values for smaller objects, most notably for ¹¹¹In. SPECT quantification was affected by the partial volume effect in smaller objects and generally showed larger errors than the planar results in these cases for all radionuclides. For the cardiac phantom, results were the most accurate of all of the experiments for all radionuclides. Background subtraction was an important factor influencing these results. The contribution of scattered photons was important in quantification with ¹³¹I; if scatter was not accounted for, activity tended to be overestimated using planar quantification methods. For the torso phantom experiments, results show a clear underestimation of activity when compared to previous experiment with spherical sources for all radionuclides. Despite some variations that were observed as the level of background increased, the SPECT results were more consistent across different activity concentrations. Planar or SPECT quantification on state-of-the-art gamma cameras with appropriate quantitative processing can provide accuracies of better than 10% for large objects and modest target-to-background concentrations; however when smaller objects are used, in the presence of higher background, and for nuclides with more complex decay schemes, SPECT quantification methods generally produce better results.

Entities:  

Mesh:

Year:  2010        PMID: 20938240      PMCID: PMC2954504          DOI: 10.1097/HP.0b013e3181e28cdb

Source DB:  PubMed          Journal:  Health Phys        ISSN: 0017-9078            Impact factor:   1.316


  27 in total

1.  An activity quantification method based on registration of CT and whole-body scintillation camera images, with application to 131I.

Authors:  Katarina Sjögreen; Michael Ljungberg; Sven-Erik Strand
Journal:  J Nucl Med       Date:  2002-07       Impact factor: 10.057

2.  Radioimmunotherapy with yttrium 90 ibritumomab tiuxetan (Zevalin): the role of the nuclear medicine physician.

Authors:  Peter S Conti
Journal:  Semin Nucl Med       Date:  2004-01       Impact factor: 4.446

Review 3.  An overview of attenuation and scatter correction of planar and SPECT data for dosimetry studies.

Authors:  Michael King; Troy Farncombe
Journal:  Cancer Biother Radiopharm       Date:  2003-04       Impact factor: 3.099

4.  Comparison of conventional, model-based quantitative planar, and quantitative SPECT image processing methods for organ activity estimation using In-111 agents.

Authors:  Bin He; Eric C Frey
Journal:  Phys Med Biol       Date:  2006-08-02       Impact factor: 3.609

5.  Calculation and validation of the use of effective attenuation coefficient for attenuation correction in In-111 SPECT.

Authors:  Youngho Seo; Kenneth H Wong; Bruce H Hasegawa
Journal:  Med Phys       Date:  2005-12       Impact factor: 4.071

6.  Preliminary validation of the opposing view method for quantitative gamma camera imaging.

Authors:  J F Eary; F L Appelbaum; L Durack; P Brown
Journal:  Med Phys       Date:  1989 May-Jun       Impact factor: 4.071

7.  Importance of pre-treatment radiation absorbed dose estimation for radioimmunotherapy of non-Hodgkin's lymphoma.

Authors:  J F Eary; K A Krohn; O W Press; L Durack; I D Bernstein
Journal:  Nucl Med Biol       Date:  1997-10       Impact factor: 2.408

8.  Accurate dosimetry in 131I radionuclide therapy using patient-specific, 3-dimensional methods for SPECT reconstruction and absorbed dose calculation.

Authors:  Yuni K Dewaraja; Scott J Wilderman; Michael Ljungberg; Kenneth F Koral; Kenneth Zasadny; Mark S Kaminiski
Journal:  J Nucl Med       Date:  2005-05       Impact factor: 10.057

9.  Patient-specific, 3-dimensional dosimetry in non-Hodgkin's lymphoma patients treated with 131I-anti-B1 antibody: assessment of tumor dose-response.

Authors:  George Sgouros; Shannon Squeri; Ase M Ballangrud; Katherine S Kolbert; Jerrold B Teitcher; Katherine S Panageas; Ronald D Finn; Chaitanya R Divgi; Steven M Larson; Andrew D Zelenetz
Journal:  J Nucl Med       Date:  2003-02       Impact factor: 10.057

10.  External imaging techniques for quantitation of distribution of I-131 F(ab')2 fragments of monoclonal antibody in humans.

Authors:  N D Hammond; P J Moldofsky; M R Beardsley; C B Mulhern
Journal:  Med Phys       Date:  1984 Nov-Dec       Impact factor: 4.071

View more
  13 in total

1.  Chemoradionuclide therapy with 186re-labeled liposomal doxorubicin: toxicity, dosimetry, and therapeutic response.

Authors:  Anuradha Soundararajan; Ande Bao; William T Phillips; Linda M McManus; Beth A Goins
Journal:  Cancer Biother Radiopharm       Date:  2011-08-11       Impact factor: 3.099

2.  Activity quantification combining conjugate-view planar scintigraphies and SPECT/CT data for patient-specific 3-D dosimetry in radionuclide therapy.

Authors:  Yannick Berker; Andreas Goedicke; Gerrit J Kemerink; Til Aach; Bernd Schweizer
Journal:  Eur J Nucl Med Mol Imaging       Date:  2011-09-08       Impact factor: 9.236

3.  The role of patient-based treatment planning in peptide receptor radionuclide therapy.

Authors:  Deni Hardiansyah; Christian Maass; Ali Asgar Attarwala; Berthold Müller; Peter Kletting; Felix M Mottaghy; Gerhard Glatting
Journal:  Eur J Nucl Med Mol Imaging       Date:  2015-11-18       Impact factor: 9.236

4.  MIRD pamphlet No. 24: Guidelines for quantitative 131I SPECT in dosimetry applications.

Authors:  Yuni K Dewaraja; Michael Ljungberg; Alan J Green; Pat B Zanzonico; Eric C Frey; Wesley E Bolch; A Bertrand Brill; Mark Dunphy; Darrell R Fisher; Roger W Howell; Ruby F Meredith; George Sgouros; Barry W Wessels
Journal:  J Nucl Med       Date:  2013-10-15       Impact factor: 10.057

5.  Quantitative (177)Lu SPECT (QSPECT) imaging using a commercially available SPECT/CT system.

Authors:  Jean-Mathieu Beauregard; Michael S Hofman; Jucilene M Pereira; Peter Eu; Rodney J Hicks
Journal:  Cancer Imaging       Date:  2011-06-15       Impact factor: 3.909

6.  Common strategic research agenda for radiation protection in medicine.

Authors: 
Journal:  Insights Imaging       Date:  2017-02-15

7.  Estimation of Organ Absorbed Doses in Patients from (99m)Tc-diphosphonate Using the Data of MIRDose Software.

Authors:  Daryoush Shahbazi-Gahrouei; Mohsen Cheki; Masoud Moslehi
Journal:  J Med Signals Sens       Date:  2012-10

8.  Comparison of the Absorbed Dose for (99m)Tc-Diethylenetriaminepentaacetic Acid and (99m)Tc-Ethylenedicysteine Radiopharmaceuticals using Medical Internal Radiation Dosimetry.

Authors:  Shokufeh Pirdamooie; Ahmad Shanei; Masoud Moslehi
Journal:  J Med Signals Sens       Date:  2015 Jul-Sep

9.  Improving quantitative dosimetry in (177)Lu-DOTATATE SPECT by energy window-based scatter corrections.

Authors:  Robin de Nijs; Vera Lagerburg; Thomas L Klausen; Søren Holm
Journal:  Nucl Med Commun       Date:  2014-05       Impact factor: 1.690

10.  Estimation of Organ Activity using Four Different Methods of Background Correction in Conjugate View Method.

Authors:  Ahmad Shanei; Maryam Afshin; Masoud Moslehi; Sedighe Rastaghi
Journal:  J Med Signals Sens       Date:  2015 Oct-Dec
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.